Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tobacco Use 1Tobacco Smoking 1Testicular Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Health Behavior 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Costs and Cost Analysis × Clear all
NCT05471284 2022-07-22

Recruitment Messages for Current Smokers Recently Diagnosed With Cancer

University of Oklahoma

Phase NA Completed
99 enrolled

Tobacco Smoking, Neoplasms, Health Behavior, Tobacco Use

Data powered by HemOnc (CC BY 4.0) Colophon âš¡